ADHERIUM LIMITED (ADR)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for ADR during the last 90 days, indicating Moderate trading activity

Latest ADR Signals
26/06/2026	SELL
ADR Share Price
Current Price	$0.150
52 Week High	$0.150
52 Week Low:	$0.002
Trading at (% of 52 Week High)	100.00%

Business Overview

Adherium Limited (ASX: ADR) develops digital health products designed to improve medication adherence for people with asthma and chronic obstructive pulmonary disease (COPD). The company offers smart inhaler sensors and connected software solutions to help patients manage their respiratory conditions more effectively.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The SELL recommendation for ADHERIUM LIMITED is supported by the extremely low stock price indicating potential liquidity issues and limited market interest. However, the confidence is moderated by the lack of detailed financial data and recent performance metrics.

Latest  ADHERIUM LIMITED(ADR)   News